These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 18534254

  • 1. The pentylenetetrazole-induced activity in the hippocampus can be inhibited by the conversion of L-kynurenine to kynurenic acid: an in vitro study.
    Rozsa E, Robotka H, Nagy D, Farkas T, Sas K, Vecsei L, Toldi J.
    Brain Res Bull; 2008 Jul 30; 76(5):474-9. PubMed ID: 18534254
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
    Harris CA, Miranda AF, Tanguay JJ, Boegman RJ, Beninger RJ, Jhamandas K.
    Br J Pharmacol; 1998 May 30; 124(2):391-9. PubMed ID: 9641558
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pretreatment with L-kynurenine, the precursor to the excitatory amino acid antagonist kynurenic acid, suppresses epileptiform activity in combined entorhinal/hippocampal slices.
    Scharfman HE, Ofer A.
    Neurosci Lett; 1997 Mar 14; 224(2):115-8. PubMed ID: 9086470
    [Abstract] [Full Text] [Related]

  • 10. Kynurenate and 7-chlorokynurenate formation in chronically epileptic rats.
    Wu HQ, Rassoulpour A, Goodman JH, Scharfman HE, Bertram EH, Schwarcz R.
    Epilepsia; 2005 Jul 14; 46(7):1010-6. PubMed ID: 16026552
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Homocysteine, a risk factor for atherosclerosis, biphasically changes the endothelial production of kynurenic acid.
    Stazka J, Luchowski P, Urbanska EM.
    Eur J Pharmacol; 2005 Jul 11; 517(3):217-23. PubMed ID: 15961072
    [Abstract] [Full Text] [Related]

  • 16. Neuroprotective effects of L-kynurenine on hypoxia-ischemia and NMDA lesions in neonatal rats.
    Nozaki K, Beal MF.
    J Cereb Blood Flow Metab; 1992 May 11; 12(3):400-7. PubMed ID: 1569135
    [Abstract] [Full Text] [Related]

  • 17. In situ-produced 7-chlorokynurenate has different effects on evoked responses in rats with limbic epilepsy in comparison to naive controls.
    Zhang DX, Williamson JM, Wu HQ, Schwarcz R, Bertram EH.
    Epilepsia; 2005 Nov 11; 46(11):1708-15. PubMed ID: 16302850
    [Abstract] [Full Text] [Related]

  • 18. Kynurenines do not antagonise GABA in rat hippocampus.
    Stone TW.
    Eur J Pharmacol; 1986 Aug 22; 128(1-2):81-3. PubMed ID: 3758189
    [Abstract] [Full Text] [Related]

  • 19. The effects of group III mGluR ligands on pentylenetetrazol-induced kindling of seizures and hippocampal amino acids concentration.
    Maciejak P, Szyndler J, Turzyńska D, Sobolewska A, Taracha E, Skórzewska A, Lehner M, Bidziński A, Hamed A, Wisłowska-Stanek A, Płaźnik A.
    Brain Res; 2009 Jul 28; 1282():20-7. PubMed ID: 19481536
    [Abstract] [Full Text] [Related]

  • 20. Enhancement of brain kynurenic acid production by anticonvulsants--novel mechanism of antiepileptic activity?
    Kocki T, Wielosz M, Turski WA, Urbanska EM.
    Eur J Pharmacol; 2006 Jul 17; 541(3):147-51. PubMed ID: 16765940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.